These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9916888

  • 1. An inhibitor of inducible nitric oxide synthase ameliorates experimental autoimmune myocarditis in Lewis rats.
    Shin T, Tanuma N, Kim S, Jin J, Moon C, Kim K, Kohyama K, Matsumoto Y, Hyun B.
    J Neuroimmunol; 1998 Dec 01; 92(1-2):133-8. PubMed ID: 9916888
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats.
    Ishiyama S, Hiroe M, Nishikawa T, Shimojo T, Hosokawa T, Ikeda I, Toyozaki T, Kasajima T, Marumo F.
    Cardiovasc Res; 1999 Aug 01; 43(2):389-97. PubMed ID: 10536669
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase.
    Zhao W, Tilton RG, Corbett JA, McDaniel ML, Misko TP, Williamson JR, Cross AH, Hickey WF.
    J Neuroimmunol; 1996 Feb 01; 64(2):123-33. PubMed ID: 8632054
    [Abstract] [Full Text] [Related]

  • 8. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction.
    Eriksson U, Kurrer MO, Bingisser R, Eugster HP, Saremaslani P, Follath F, Marsch S, Widmer U.
    Circulation; 2001 Jan 02; 103(1):18-21. PubMed ID: 11136679
    [Abstract] [Full Text] [Related]

  • 9. The role of selective nitric oxide synthase inhibitor on nitric oxide and PGE2 levels in refractory hemorrhagic-shocked rats.
    Md S, Moochhala SM, Siew Yang KL, Lu J, Anuar F, Mok P, Ng KC.
    J Surg Res; 2005 Feb 02; 123(2):206-14. PubMed ID: 15680380
    [Abstract] [Full Text] [Related]

  • 10. Aminoguanidine inhibits mitogen-activated protein kinase and improves cardiac performance and cardiovascular remodeling in failing hearts of salt-sensitive hypertensive rats.
    Kobayashi N, Horinaka S, Mita S, Yoshida K, Honda T, Kobayashi T, Hara K, Nishikimi T, Matsuoka H.
    J Hypertens; 2002 Dec 02; 20(12):2475-85. PubMed ID: 12473873
    [Abstract] [Full Text] [Related]

  • 11. cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats.
    Yokoseki O, Suzuki J, Kitabayashi H, Watanabe N, Wada Y, Aoki M, Morishita R, Kaneda Y, Ogihara T, Futamatsu H, Kobayashi Y, Isobe M.
    Circ Res; 2001 Nov 09; 89(10):899-906. PubMed ID: 11701617
    [Abstract] [Full Text] [Related]

  • 12. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase.
    Wang D, Yang XP, Liu YH, Carretero OA, LaPointe MC.
    Am J Hypertens; 1999 Feb 09; 12(2 Pt 1):174-82. PubMed ID: 10090345
    [Abstract] [Full Text] [Related]

  • 13. Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU).
    Bora NS, Sohn JH, Bora PS, Kaplan HJ, Kulkarni P.
    Ocul Immunol Inflamm; 2005 Feb 09; 13(2-3):183-9. PubMed ID: 16019677
    [Abstract] [Full Text] [Related]

  • 14. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/reperfusion injury.
    Ding HL, Zhu HF, Dong JW, Zhu WZ, Yang WW, Yang HT, Zhou ZN.
    Acta Pharmacol Sin; 2005 Mar 09; 26(3):315-22. PubMed ID: 15715927
    [Abstract] [Full Text] [Related]

  • 15. Aminoguanidine-induced amelioration of autoimmune encephalomyelitis is mediated by reduced expression of inducible nitric oxide synthase in the spinal cord.
    Shin T, Kim S, Moon C, Wie M, Kim H.
    Immunol Invest; 2000 Aug 09; 29(3):233-41. PubMed ID: 10933607
    [Abstract] [Full Text] [Related]

  • 16. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats.
    Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T.
    J Mol Cell Cardiol; 1997 Feb 09; 29(2):491-502. PubMed ID: 9140809
    [Abstract] [Full Text] [Related]

  • 17. Role of inducible nitric oxide synthase in the cerebral vasospasm after subarachnoid hemorrhage in rats.
    Sayama T, Suzuki S, Fukui M.
    Neurol Res; 1999 Apr 09; 21(3):293-8. PubMed ID: 10319339
    [Abstract] [Full Text] [Related]

  • 18. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases after traumatic spinal cord injury: effect of aminoguanidine treatment.
    Chatzipanteli K, Garcia R, Marcillo AE, Loor KE, Kraydieh S, Dietrich WD.
    J Neurotrauma; 2002 May 09; 19(5):639-51. PubMed ID: 12042098
    [Abstract] [Full Text] [Related]

  • 19. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Reddy BS.
    Cancer Res; 2002 Jan 01; 62(1):165-70. PubMed ID: 11782374
    [Abstract] [Full Text] [Related]

  • 20. Expression of inducible nitric oxide synthase in transplanted rat liver and its inhibitory effect.
    Wang GY, Meng W, Ji B, Du XH, Zhao J.
    Hepatobiliary Pancreat Dis Int; 2005 Aug 01; 4(3):360-3. PubMed ID: 16109516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.